Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 887 results for "novartis"

Novartis, Swiss pharma company, under investigation for bribery in Greece
Deutsche Welle

Greece: Novartis pharma company under investigation

The Greek authorities are investigating the Swiss pharmaceutical giant Novartis over allegations of bribery and price inflation. One minister has said these could involve "illegal earnings of over four billion euros." Rumours of the scandal have ... Deutsche Welle, 1 hour ago

767 images for novartis

Dotemirates.com, 1 hour ago
Post Online Media, 2 days ago
American Banking News, 2 days ago
Post Online Media, 4 days ago
Post Online Media, 3 days ago
SleekMoney, 3 days ago
Yahoo! India, 4 days ago
Yahoo! India, 4 days ago
Moneycontrol.com, 4 days ago
Reuters India, 4 days ago

Novartis's 4Q16 Earnings: What Is Expected?

. Analysts estimate its 4Q16 earnings per share to
 Yahoo! Finance1 day ago European markets open higher; earnings to dominate  Money Control2 months ago
PharmaVOICE

Obamacare Replacement May Improve Patient Access, Novartis Says

Drugmakers want patients to have more access to new medicines Path ahead may not be as draconian as feared, CEO says Repealing and replacing Obamacare could benefit the pharmaceutical industry if it allows drugmakers to get cutting-edge new ...
 Bloomberg1 day ago Astellas Announces Participation in Access Accelerated  Nasdaq4 days ago Astellas Release: Pharma Announces Participation In Access Accelerated  BioSpace3 days ago
[x]  
Mr Top Step

Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?

Swiss pharmaceutical company Novartis AG NVS is scheduled to report fourth-quarter and full year 2016 results on Jan 25.View photos A look at Novartis share price movement in the last 12 months shows that the stock has underperformed the Zacks ...
 Yahoo! Finance1 day ago
[x]  
Reuters

Novartis CEO: Trump Understands Value of Drug Innovation

Joe Jimenez, Novartis chief executive officer, discusses the outlook for the pharmaceutical industry under President Donald Trump. He speaks with Bloomberg's Erik Schatzker at the World Economic Forum in Davos, Switzerland.
 Bloomberg2 days ago Interview with Joseph Jimenez, CEO of Novartis, from the World Economic Forum 2017  CNBC4 days ago We will continue to invest: Novartis CEO  Yahoo! Finance4 days ago BRIEF-Novartis CEO says sees downward pressure on pharma prices -CNBC  Reuters UK4 days ago
[x]  

Novartis India Ltd calls for Board Meeting Intimation for Results

Posted On: 2017-01-21 04:04:32 A meeting of the Board of Directors of Novartis India Ltd will be held on February 03, 2017, to consider unaudited financial results of the Company for third quarter and nine months ended December 31, 2016. Shares ...
 Equity Bulls1 day ago Novartis India to consider Q3 and 9M results  Business Standard3 days ago Novartis India's board meeting on February 03, 2017  Money Control3 days ago 2016 Review/2017 Preview Novartis  FirstWord Pharma5 days ago

Pharmaceuticals only a small fraction of healthcare costs...

CNBC VideosJanuary 18, 2017 Novartis CEO Joe Jimenez discusses how his sector may develop under Donald
 Yahoo! Finance4 days ago Trump could boost pharma but Obamacare needs to be replaced if repealed, CEO of drug giant says  CNBC4 days ago Don't cut prices, cut taxes, pharma CEO tells Trump  pharmaphorum4 days ago
[x]  

Obamacare Repeal May Help Pharmaceutical Industry, Novartis Says

Dru
 Bloomberg2 days ago

Roche's Franz: No Talks With Novartis on Stake Sale

Christoph Franz, chairman at Roche Holding, looks at what repealing and replacing of Obamacare can mean for the company and customers and discusses drug pricing and concerns about globalization. He speaks with Bloomberg's Francine Lacqua from the ...
 Bloomberg3 days ago NOVARTIS CEO SAYS ROCHE STAKE SALE TIMING DEPENDS ON GETTING GOOD MARKET PRICE  Sharenet4 days ago

Novartis CEO Discusses Impact of Trump on Drug Industry

Novartis CEO Joseph Jimenez spoke to WSJ's Deborah Ball about the impact that a Trump presidency could have on the
 Yahoo! Finance4 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less